58
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T24016 |
DPP-4-PIOL
DPP4PIOL |
||
DPP-4-PIOL is an antagonist of GABAA. In dentate gyrus granule cells, it acts by selectively antagonizing tonic over phasic GABAergic currents. | |||
T11526 |
DPP-IV-IN-2
H-Lys(4-nitro-Z)-pyrrolidide |
DPP-4 | Proteases/Proteasome |
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) 是二肽基肽酶 IV 和DP8/9的抑制剂, IC50分别为 0.1 和 0.95 μM。 | |||
T7133 |
Anagliptin
SK-0403,阿拉格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Anagliptin (SK-0403) 是一种选择性的二肽酰肽酶 4 抑制剂,IC50=3.8 nM,对 DPP-8/9 的选择性相对较弱,IC50分别为 68 和 60 nM。 | |||
T6192 |
Alogliptin
SYR-322,阿格列汀,阿洛利停 |
Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Alogliptin (SYR-322) 是一种具有选择性口服活性的DPP-4的抑制剂,IC50值小于 10 nM,比对 DPP-8 和 DPP-9 的抑制性高 10000 倍以上,可研究 2 型糖尿病。 | |||
T12710 |
Retagliptin Phosphate
SP 2086,瑞格列汀磷酸盐 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Retagliptin Phosphate (SP 2086) 是一种选择性、竞争性、口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin phosphate 能够用于 2 型糖尿病 (T2DM) 的研究。 | |||
T2401 |
Alogliptin Benzoate
苯甲酸阿格列汀,SYR 322,Alogliptin(SYR-322)benzoate |
Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Alogliptin Benzoate (SYR 322) 是一种有效且特异性的 DPP-4 抑制剂 ,IC50值小于 10 nM,其选择性比 DPP-8/9 高 10,000 倍以上,可用于研究 2 型糖尿病。 | |||
T6203 |
Saxagliptin
BMS-477118,沙克列汀,Onglyza,沙格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin (BMS-477118) 是一种选择性,可逆性,竞争性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin 能够用于 2 型糖尿病的研究。 | |||
T0178 |
Saxagliptin hydrate
沙格列汀单水化合物,Onglyza hydrate,BMS-477118 hydrate |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin hydrate (Onglyza hydrate) 是一种选择性,竞争性,可逆性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin hydrate 能够用于 2 型糖尿病的研究。 | |||
T61414 | DPP-4 inhibitor 3 | ||
DPP-4 inhibitor 3 (Compound 5a) 是一种有效的二肽基肽酶 IV (DPP-IV) 抑制剂,IC50为 0.75 nM。DPP-4 inhibitor 3 具有极好的抗氧化和胰岛素性活性。 | |||
T74528 | DPP-4/GPR119 modulator 1 | ||
DPP-4/GPR119 modulator 1 (Compound 22) 是一种具有口服活性的二肽基肽酶 IV (DPP-IV) 抑制剂和 GPR119激动剂。DPP-4/GPR119 modulator 1 具有降血糖作用,抑制hERG 通道,IC50值为 4.9 µM。DPP-4/GPR119 modulator 1 可用于糖尿病的研究。 | |||
T63964 |
DPP-4/GPR119 modulator 2
|
||
DPP-4/GPR119 modulator 2 是二肽基肽酶 IV (DPP-IV) 抑制剂 (IC50: 0.22 μM),也是一种 GPR119 激动剂 (EC50: 0.95 μM)。DPP-4/GPR119 modulator 2 能够用于研究糖尿病。 | |||
T7369L |
Gemigliptin Tartrate(911637-19-9 free base)
吉格列汀酒石酸盐,LC15-0444 tartrate |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Gemigliptin Tartrate (LC15-0444 tartrate) 是一种选择性的,可逆的,竞争性的二肽基肽酶 4 (DPP-4) 抑制剂,对于人重组 DPP-4 的IC50=10.3 nM。Gemigliptin tartrate 具有很强的抗糖基化活性,能够用于晚期糖基化终产物相关的糖尿病并发症的研究。 | |||
T61422 |
DPP-4-IN-1
|
||
DPP-4-IN-1 (compound d1) is a highly potent inhibitor of DPP-4 (dipeptidyl peptidase 4) with an IC 50 of 49 nM, making it suitable for diabetes research [1]. It shares structural similarities to Alogliptin and can be effectively utilized for studying diabetes-related mechanisms. | |||
T61018 |
DPP-4-IN-2
|
||
DPP-4-IN-2 (compound b2) 是 Alogliptin 的结构类似物,可以用于研究糖尿病。DPP-4-IN-2 是二肽基肽酶 4 (DPP-4)的有效抑制剂,IC50值为 79 nM。 | |||
T79256 |
DPP-4-IN-8
|
||
DPP-4-IN-8 (compound 27) 是一种高效的选择性DPP4抑制剂,具有 0.96 μM 的 Ki。该化合物能够抑制 Caco-2 和 HepG-2 细胞中的 DPP4 二肽酶活性,并剂量依赖性地降低 TNF-α、IL-6 和 IL-1β 的表达水平[1]。 | |||
T7369 |
Gemigliptin
吉格列汀酒石酸盐,LC15-0444 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Gemigliptin (LC15-0444) 是一种选择性的,可逆的,竞争性的二肽基肽酶 4 (DPP-4) 抑制剂,对人重组 DPP-4 的 IC50=10.3 nM。Gemigliptin 具有很强的抗糖基化活性,能够用于晚期糖基化终产物相关的糖尿病并发症的研究。 | |||
T1581 |
Picolamine
|
DPP-4 | Proteases/Proteasome |
Picolamine 可作为 DPP-4 的潜在抑制剂。 | |||
T29019 |
TS-021
TS021,TS 021,TS-021 Free |
DPP-4 | Proteases/Proteasome |
TS-021 是一种具有选择性的二肽基肽酶 4 (DPP-4) 抑制剂,具有抗糖尿病活性,可用于研究2 型糖尿病。 | |||
T6237 |
Trelagliptin
SYR-472,曲格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Trelagliptin (SYR-472) 是一种有效的,具有口服活性的DPP-4抑制剂,IC50=4 nM。它可以改善体内血糖控制,能够用于2 型糖尿病 (T2DM) 的研究。 | |||
T1502 |
Vildagliptin
维达列汀,NVP-LAF 237,维格列汀,LAF237 |
Apoptosis; Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Vildagliptin (LAF237) 是一种选择性二肽基肽酶IV (DPP-IV) 抑制剂,在人 Caco-2 细胞中抑制 DPP-IV 的IC50为 3.5 nM。它具有出色的口服生物利用度和降血糖活性。 | |||
T0191 |
Linagliptin
BI 1356,利格列汀,利拉利汀 |
Ferroptosis; Proteasome; DPP-4; Autophagy | Apoptosis; Autophagy; Proteases/Proteasome; Ubiquitination |
Linagliptin (BI 1356) 是一种有效的、可口服的、基于二氢嘌呤二酮的二肽基肽酶 4 抑制剂,具有降血糖活性。 | |||
T2296 |
Trelagliptin succinate
曲格列汀琥珀酸盐,琥珀酸曲格列汀,SYR-472 succinate,SYR472 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Trelagliptin succinate (SYR-472 succinate) 是一种有效的,具有口服活性的DPP-4抑制剂,IC50=4 nM。它可以改善体内血糖控制,能够用于2 型糖尿病(T2DM) 的研究。 | |||
T68053 |
Denagliptin
GW823093 |
DPP-4 | Proteases/Proteasome |
Denagliptin是一种小分子二肽基肽酶IV(DPP-4)抑制剂,可用于治疗内分泌于代谢疾病,可用于研究2型糖尿病。 | |||
T6999 |
Teneligliptin hydrobromide
Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) |
Others; Proteasome; DPP-4 | Others; Proteases/Proteasome; Ubiquitination |
Teneligliptin hydrobromide (MP-513(hydrobromide)) 是β2肾上腺素能受体 (β2AR) 阻滞剂,具有抗高血压、抗氧化、清除自由基的活性。 | |||
T0242 |
Sitagliptin
西他列汀,MK0431,西格列汀 |
Proteasome; DPP-4; Autophagy | Autophagy; Proteases/Proteasome; Ubiquitination |
Sitagliptin (MK0431) 是一种有效的 DPP4抑制剂,在 Caco-2 细胞中,IC50值为 19 nM。它是一种新型口服降糖药,可单独使用或与二甲双胍或噻唑烷二酮联合用于治疗 2 型糖尿病。 | |||
T28520 |
Retagliptin
SP-2086,SP2086,SP 2086 |
||
Retagliptin is a DPP-4 inhibitor potentially used to treat Type 2 diabetes. | |||
T30166 |
ASP-4000 HCl
ASP4000 HCl,ASP 4000 HCl,UNII-7393JFE67B |
||
ASP-4000 HCl is an inhibitor of dipeptidyl peptidase 4 (DPP) with anti-hyperglycemic activity. | |||
T35815 |
Vildagliptin carboxylic acid metabolite (trifluoroacetate salt)
|
||
Vildagliptin carboxylic acid metabolite is the major metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor vildagliptin in humans. Vildagliptin carboxylic acid metabolite has an IC50 value of 477 μM for DPP-4 in human Caco-2 cells. It is formed from hydrolysis of the cyano group on vildagliptin. | |||
T63915 | Sitagliptin fenilalanil | ||
Sitagliptin fenilalanil 是一种二肽氨基肽酶 (DPP-4)抑制剂。 | |||
T41250 |
Teneligliptin hydrobromide hydrate
|
||
Teneligliptin hydrobromide hydrate 是一种有效的 DPP-4抑制剂,可在体外竞争性抑制人血浆、大鼠血浆和重组人 DPP-4 ,IC50值约为 1 nM。 | |||
T74592 |
Sitagliptin fenilalanil hydrochloride
|
||
Sitagliptin fenilalanil hydrochloride 是一种二肽氨基肽酶 (DPP-4) 抑制剂。 | |||
T29970 |
AMG-222
AMG 222,ALS-2-0426 free base,ALS-2-0426,ALS-20426 |
||
AMG-222 (ALS-2-0426, ALS-20426) is a DPP-4 inhibitor and may be used in the treatment of type 2 diabetes. | |||
T26777 |
Besigliptin Tosylate
SHR 117887,SHR-117887,SHR117887 |
||
Besigliptin Tosylate, a DPP-4 inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T68561 |
ASP-4000 free base
|
||
ASP-4000 free base is a dipeptidyl peptidase 4 (DPP) inhibitor with antihyperglycemic activity. | |||
T26857 |
BMS-767778
|
||
BMS-767778, a DPP-4 inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T26941 |
Camegliptin
RO-4876904-001,R1579,RG1579,RO-4876904,R-1579,RG-1579 |
||
Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T27598 |
Imigliptin Dihydrochloride
Imigliptin |
||
Imigliptin Dihydrochloride, a selective dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type II diabetes. | |||
T68652 | Carmegliptin dihydrochloride | ||
Carmegliptin dihydrochloride is the salt form of Camegliptin (free base), also known as RG-1579 and RO4876904, a dipeptidyl peptidase IV (DPP-4) inhibitor potentially for the treatment of type 2 diabetes. | |||
T11248 |
Evogliptin tartrate
DA-1229 tartrate |
DPP-4 | Proteases/Proteasome |
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity. | |||
T13121 |
Teneligliptin D8
MP-513 D8 |
Others | Others |
Teneligliptin D8 a deuterium labeled Teneligliptin (MP-513). Teneligliptin is a potent, orally available, competitive, and long-lasting inhibitor of DPP-4. | |||
T62213 |
Anagliptin hydrochloride
|
||
Anagliptin (SK-0403) hydrochloride 是一种有效的、高度选择性的、口服具有活力的二肽酰肽酶 4 (DPP-4) 抑制剂 (IC50: 3.8 nM),对 DPP-8 (IC50: 68 nM) 和 DDP-9 (IC50: 60 nM) 的选择性相对较弱。 | |||
T76922 | Begelomab | ||
Begelomab (SAND-26) 是一种针对 DPP-4/CD26的鼠IgG2b 单克隆抗体。 Begelomab 可用于严重难治性特发性炎症性肌病的研究。 | |||
T71831 |
L-Ornithine lactam hydrochloride
|
||
L-Ornithine lactam is a synthetic intermediate. It has been used in the synthesis of dipeptidyl peptidase 4 (DPP-4) inhibitors, as well as signaling peptides. | |||
T35440 |
(-)-Sitagliptin Carbamoyl Glucuronide
|
||
(-)-Sitagliptin carbamoyl glucuronide is a minor phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin . (-)-Sitagliptin carbamoyl glucuronide is formed by N-carbamoyl glucuronidation and has been found in rat and dog plasma following administration of (-)-sitagliptin. | |||
T68863 | MK-0626 free base | ||
MK-0626 is a Dipeptidyl peptidase IV (DPP-4) inhibitor, improving neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression. | |||
T10288 |
Alogliptin (13CD3)
SYR-322 (13CD3) |
Others | Others |
Alogliptin (SYR-322) 13CD3 is the deuterium-labeled Alogliptin. Alogliptin is a selective inhibitor of DPP-4. | |||
T35637 | Sitagliptin N-Sulfate (sodium salt) | ||
Sitagliptin N-sulfate is a phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin . Sitagliptin N-sulfate is formed via sulfation and has been found in rat bile following oral administration of (-)-sitagliptin. | |||
T6203L |
Saxagliptin hydrochloride
BMS477118,Saxagliptin,BMS 477118,Saxagliptin HCl,BMS-477118 |
||
Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose conce | |||
T37522 | Teneligliptin | ||
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneligliptin (MP-513) inhibits all these DPP-4 enzymes in a concentration-dependent manner. The IC50s of Teneligliptin (MP-513) for rhDPP-4, human plasma, and rat plasma are 0.889, 1.75, and 1.35 nM, respectively. A study of enzyme inhibition kinetics is conducted for Teneligliptin (M... | |||
T73875 |
Fotagliptin benzoate
|
||
Fotagliptin benzoate,作为一种二肽基肽酶IV (DPP-4) 抑制剂(IC50=2.27 nM),在大鼠和狗中展现了安全性,适用于2型糖尿病的研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1418 |
Azaleatin
杜鹃黄素,2-(3,4-二羟基苯基)-3,7-二羟基-5-甲氧基苯并吡喃-4-酮 |
DPP-4 | Proteases/Proteasome |
Azaleatin 是分离自Rhododendron 种中的 O-甲基化黄酮醇。它是二肽基肽酶-IV 的抑制剂。它在 2 型糖尿病和肥胖症中有研究的价值。 | |||
T83863 |
Fluostatin A sodium
|
||
Fluostatin A是一种最初从链霉菌中分离出的荧光酮类化合物。它对二肽基肽酶3(DPP-3)的选择性抑制作用优于对DPP-1、DPP-2和DPP-4的抑制作用(IC50s分别为0.44, >100, >100, 和 >100 µg/ml)。 | |||
T81898 |
Lyciumamide A
|
||
DPP-IV-IN-5,一种从枸杞果实中分离得到的化合物,对过氧化物酶体增殖物激活受体(PPARγ)展示中等拮抗活性,其EC50值介于10.09至44.26 μM,同时对二肽基肽酶-4 (DPPIV)亦有抑制作用,IC50值为47.13 μM。 |